The TipRanks All-star Analyst of the Day title goes to analyst Philippe Houchois of research firm Jefferies. Remarkably, ...

Synopsys’ (SNPS) CEO Sassine Ghazi, recently sold the company’s shares worth $5.37 million. SNPS is a software company that ...

Piper Sandler currently has an overweight rating on the semiconductor company’s stock. Several other brokerages also recently weighed in on SNPS. Needham & Company LLC reissued a “buy ...

Synopsys SNPS shares plunged 20.8% over the past year ... Is it time to buy the dip or wait for further clarity? Synopsys stock stalled after the first quarter of fiscal 2025 results as the ...

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, ...

Synopsys (NASDAQ:SNPS) shares rose 3% in extended-trading ... on an adjusted basis for the second quarter, while revenue is forecast to be between $1.59B and $1.62B. Analysts were expecting ...

Synopsys, Inc. SNPS will release its financial results for ... Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company ...

SNPS stock opened at $474.84 on Monday. Synopsys has a twelve month low of $457.52 and a twelve month high of $629.38. The company has a market capitalization of $73.40 billion, a P/E ratio of 32. ...

SYNOPSYS INC (SNPS) is a large-cap growth stock in the Software & Programming industry. The rating using this strategy is 88% based on the firm’s underlying fundamentals and the stock’s valuation.

12-month SNPS stock price prediction. Source: TipRanks Medical technology firm Hologic (NASDAQ ... over 30% to an average price target of $83.54 within the next 12 months. Forecasts range from a low ...